GS1 revs track/trace engine; Lean vs. innovation;

> This week marks the start of a GS1 "test engine" effort to help pharma and healthcare companies prep for upcoming drug track-and-trace requirements. Article

> True or false? Lean techniques, while valuable in manufacturing, supply chain, and other work involving formal processes, are detrimental to innovation. Article

> Notification workflow software is making its way to the regulated realm of drug making. Article

> The London-based International Society of Pharmacovigilance has named its next president: Alex Dodoo, president of the Pharmaceutical Society of Ghana. Article

> The $799 Pharmaceutical Preparation Manufacturing Industry report notes 11 percent constant annual growth over the past three years and a large dependency on personal consumption. Announcement

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.